Edited by Lorene M. Nelson, Caroline M. Tanner, Stephen K. Van Den Eeden, and Valerie M. McGuire ISBN 0-19-513379-X, Oxford University Press, New York, New York (Telephone: 800-445-9714, Fax: 919-677-1303, E-mail: [email protected], World Wide Web: http://www.oup.com), 2004, 461 pp. (hardcover) Epidemiologists interested in neurologic disorders may rely on excellent books devoted to specific conditions, such as multiple sclerosis or Parkinson’s disease, but they have a relatively limited choice of texts that cover the entire field. Neuroepidemiology ameliorates this problem by providing a comprehensive overview of the epidemiology of neurologic diseases with an eye on methodological issues. The book is structured in three parts. The first part contains an introduction to epidemiologic methods (chapters 1–3) and to genetic epidemiology (chapter 4) from a neuroepidemiologic perspective. The first three chapters are concerned with study design, effect measures, bias, and analytic methods. The second part, chapters 5–15, is a set of reviews of the epidemiology of the following neurologic disorders: Alz-heimer’s disease and vascular dementia, movement disorders, amyotrophic lateral sclerosis, multiple sclerosis, stroke, brain and spinal cord injury, peripheral neuropathy, epilepsy, migraine and tension-type headache, intracranial neoplasms, and neurodevelopmental disabilities. The last part, chapters 16–19, is dedicated to the clinical epidemiology of neurologic disorders. This part introduces prognostic studies, clinical trials, health services research, and evidence-based medicine for neurologic diseases.
No takes yet. Share an insight, caveat, or question.
Hernán et al. (2005) studied this question.